APA (7th ed.) Citation

Ascierto, P., Bastholt, L., Mohr, P., Hoeller, C., Robert, C., Larkin, J., . . . Blank, C. (2017). 1207 - EURO-VOYAGE: Effectiveness and safety of ipilimumab (IPI) administered during a European Expanded Access Programme (EAP) in patients with advanced melanoma (MEL). European Journal of Cancer, 72, S128. https://doi.org/10.1016/S0959-8049(17)30499-9

Chicago Style (17th ed.) Citation

Ascierto, P., et al. "1207 - EURO-VOYAGE: Effectiveness and Safety of Ipilimumab (IPI) Administered During a European Expanded Access Programme (EAP) in Patients with Advanced Melanoma (MEL)." European Journal of Cancer 72 (2017): S128. https://doi.org/10.1016/S0959-8049(17)30499-9.

MLA (9th ed.) Citation

Ascierto, P., et al. "1207 - EURO-VOYAGE: Effectiveness and Safety of Ipilimumab (IPI) Administered During a European Expanded Access Programme (EAP) in Patients with Advanced Melanoma (MEL)." European Journal of Cancer, vol. 72, 2017, p. S128, https://doi.org/10.1016/S0959-8049(17)30499-9.